Back
Penumbra Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
71
PEN
Penumbra
Last Price:
213.24
Seasonality Move:
8.63%
Sell
20
NBY
NovaBay Pharmaceuticals
Last Price:
0.08
Seasonality Move:
-7.96%
Buy
71
Penumbra (PEN)
is a Buy
Is Penumbra a Buy, Sell or Hold?
- The current Penumbra [PEN] share price is $210.00. The Score for PEN is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- PEN is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
20
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.09. The Score for NBY is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
PEN Stock Price Chart
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.09
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
PEN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.22 | Sell |
| Relative Strength Index (14 RSI): | 47.56 | Sell |
| Chaikin Money Flow: | -456968 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (202.8 - 217.74) | Sell |
| Bollinger Bands (100): | (217.26 - 258.66) | Sell |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 43.3 | Sell |
| Chaikin Money Flow: | 1873744 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.08 - 0.1) | Sell |
| Bollinger Bands (100): | (0.1 - 0.2) | Sell |
PEN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 205.56 | Buy |
| 20-day SMA: | 207.96 | Buy |
| 50-day SMA: | 221.83 | Sell |
| 200-day SMA: | 238.55 | Sell |
| 8-day EMA: | 207.42 | Buy |
| 20-day EMA: | 209.46 | Buy |
| 50-day EMA: | 219.88 | Sell |
| 200-day EMA: | 238.02 | Sell |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.09 | Sell |
| 20-day SMA: | 0.08 | Buy |
| 50-day SMA: | 0.11 | Sell |
| 200-day SMA: | 0.31 | Sell |
| 8-day EMA: | 0.09 | Sell |
| 20-day EMA: | 0.09 | Sell |
| 50-day EMA: | 0.11 | Sell |
| 200-day EMA: | 0.54 | Sell |
Penumbra Earnings Growth & PEN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.13 per share, an increase this year of $0.79 per share, and an increase next year of $1.00 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.04 per share, an increase this year of $2.04 per share, and an increase next year of $0.30 per share.
Penumbra Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||